Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
CDK4/6抑制剂LY2835219的临床前特性:体内细胞周期依赖性/非依赖性抗肿瘤活性(单独使用/与吉西他滨联合使用)
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-014-0120-7
Gelbert, Lawrence M; Cai, Shufen; Lin, Xi; Sanchez-Martinez, Concepcion; Del Prado, Miriam; Lallena, Maria Jose; Torres, Raquel; Ajamie, Rose T; Wishart, Graham N; Flack, Robert Steven; Neubauer, Blake Lee; Young, Jamie; Chan, Edward M; Iversen, Philip; Cronier, Damien; Kreklau, Emiko; de Dios, Alfonso